 CRANBURY, N.J., Jan. 21, 2021 GLOBE NEWSWIRE -- Amicus Therapeutics Nasdaq: FOLD, a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that three oral presentations and ten posters highlighting its development programs for Lysosomal Disorders will be included at the 17th Annual WORLDSymposiumTM 2021, to be held virtually February 8-12, 2021. 